BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2198122)

  • 21. Intravenous immune globulin in symptomatic paediatric human immunodeficiency virus infection.
    Schaad UB; Gianella-Borradori A; Perret B; Imbach P; Morell A
    Eur J Pediatr; 1988 Apr; 147(3):300-3. PubMed ID: 3134244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Substitution with immunoglobulins in primary antibody deficiency syndrome].
    Morell A; Barandun S
    Beitr Infusionther Klin Ernahr; 1982; 9():16-24. PubMed ID: 6756383
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic use of human immunoglobulins in immune deficiencies].
    Touraine JL
    Arch Fr Pediatr; 1982; 39 Suppl 1():569-72. PubMed ID: 7159180
    [No Abstract]   [Full Text] [Related]  

  • 24. IUIS/WHO notice. Appropriate uses of human immunoglobulin in clinical practice.
    Clin Exp Immunol; 1983 May; 52(2):417-22. PubMed ID: 6861378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intravenous immunoglobulins in pediatrics].
    Fontán G
    An Esp Pediatr; 1986 Aug; 25(2):77-9. PubMed ID: 3752750
    [No Abstract]   [Full Text] [Related]  

  • 26. Dose and outcomes in primary immunodeficiency disorders.
    Bonagura VR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):7-9. PubMed ID: 25546743
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antibodies: biology and clinical use].
    De Martino M; Rossi ME; Vierucci A
    Ann Sclavo Collana Monogr; 1984; 1(1):1-305. PubMed ID: 6546001
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial.
    Ammann AJ; Ashman RF; Buckley RH; Hardie WR; Krantmann HJ; Nelson J; Ochs H; Stiehm ER; Tiller T; Wara DW; Wedgwood R
    Clin Immunol Immunopathol; 1982 Jan; 22(1):60-7. PubMed ID: 6749355
    [No Abstract]   [Full Text] [Related]  

  • 29. [Properties and clinical use of human immunoglobulin preparations].
    Koehler M
    Pol Tyg Lek; 1987 Jun; 42(24):731-5. PubMed ID: 3313314
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of intravenous immunoglobulins: recommendations of a consensus conference of the working group of immunology of the Italian Society of Pediatrics.
    Ann Allergy; 1989 Apr; 62(4):362-7. PubMed ID: 2495747
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of intravenous pH 4.0 treated gamma globulin in humoral immunodeficiency disease.
    Cunningham-Rundles C; Smithwick EM; Siegal FP; Day NK; Lion A; O'Malley J; Barandun S; Good RA
    Birth Defects Orig Artic Ser; 1983; 19(3):201-3. PubMed ID: 6197105
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA approves marketing of cytomegalovirus immune globulin.
    Clin Pharm; 1990 Jul; 9(7):493. PubMed ID: 2165448
    [No Abstract]   [Full Text] [Related]  

  • 33. [The use of intravenous gamma globulin in malignant hematologic diseases].
    Garay GE
    Medicina (B Aires); 1989; 49(6):621-7. PubMed ID: 2484842
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical experience with a new immunoglobulin administered intravenously in antibody deficiency syndromes].
    Geursen RG; Bläker F; Kreth W; Rieger C; Schulte-Wissermann H
    Ric Clin Lab; 1984; 14 Suppl 2():1-6. PubMed ID: 6531617
    [No Abstract]   [Full Text] [Related]  

  • 35. New uses for intravenous immune globulin.
    Stiehm ER
    N Engl J Med; 1991 Jul; 325(2):123-5. PubMed ID: 2052046
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravenous immunoglobulin: new clinical applications.
    Steele RW; Burks AW; Williams LW
    Ann Allergy; 1988 Feb; 60(2):89-94. PubMed ID: 2829663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with sandoglobulin in bone marrow transplantation.
    Tutschka PJ; Copelan EA
    Int J Cell Cloning; 1986; 4 Suppl 1():181-8. PubMed ID: 3018102
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical trial of sulfonated immunoglobulin preparation for intravenous administration. I. Replacement therapy for primary immunodeficiency syndromes.
    Kobayashi N; Gohya N; Matsumoto S
    Eur J Pediatr; 1981 May; 136(2):159-65. PubMed ID: 6164554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Educational program for doctors and nurses taking care for primary immunodeficiency patients treated with subcutaneous immunoglobulins].
    Lewandowicz-Uszyńska A; Szaflarska A; Pietrucha B; Tarnowska I
    Pol Merkur Lekarski; 2011 Jun; 30(180):452-7. PubMed ID: 21751558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bringing immunoglobulin knowledge up to date: how should we treat today?
    Misbah S; Kuijpers T; van der Heijden J; Grimbacher B; Guzman D; Orange J
    Clin Exp Immunol; 2011 Oct; 166(1):16-25. PubMed ID: 21762127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.